栄養上のリスクのある入院患者の個別化された栄養補助:ランダム化臨床試験
Philipp Schuetz1, Rebecca Fehr2, Valerie Baechli2
1Medical University Department, Division of General Internal and Emergency Medicine, Kantonsspital Aarau, Aarau, Switzerland; Medical Faculty of the University of Basel, Basel, Switzerland.
Lancet (London, England)
|April 30, 2019
まとめ
リスクの高い入院患者に対する個別化された栄養補助は,標準的な病院の食事と比較して生存率を含む臨床結果を大幅に改善しました. これは 患者の回復のために 栄養学的スクリーニングと介入の重要性を強調しています
科学分野:
- 臨床栄養について
- 病院 医療
- 患者 の 結果
背景:
- 現在のガイドラインは,リスクの高い入院患者に対する栄養補助を推奨しています.
- これらの推奨を裏付ける証拠は限られており,急性疾患における栄養療法による潜在的な悪影響に関する懸念がある.
研究 の 目的:
- プロトコルによる個別化された栄養補助が栄養上のリスクのある入院患者の臨床結果を改善するかどうかをテストする.
主な方法:
- 栄養不良の入院患者の脆弱性,機能的アウトカム,回復に対する早期の栄養支援の効果 (EFFORT) は,多センターのランダム化研究でした.
- 栄養上のリスクのある2088人の医療従事者は,個別化された栄養補助または標準的な病院の食事を受けることを割り当てられました.
- 主要エンドポイントは,30日後の不良臨床結果の複合でした.
主要な成果:
- 個別的な栄養補助を受けた患者の23%は,対照群の27%に対して有害な結果を経験した (OR 0. 79, p=0. 023).
- 死亡率は介入群で低かった (7% vs 10%, OR 0.65, p=0. 011).
- 副作用の有意な違いは観察されなかった.
結論:
- リスクの高い入院患者の個別化された栄養補助は,生存率を含む臨床結果を改善します.
- 栄養上のリスクのある入院患者にとって 体系的な栄養学的スクリーニングと 適時な介入が不可欠です
さらに関連する動画
関連する概念動画
The Roles of Bacteria and Fungi in Plant Nutrition
47.2K
Plants have the impressive ability to create their own food through photosynthesis. However, plants often require assistance from organisms in the soil to acquire the nutrients they need to function correctly. Both bacteria and fungi have evolved symbiotic relationships with plants that help the species to thrive in a wide variety of environments.
47.2K
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
846
Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
846
Microbial Nutrition
1.2K
Organisms exhibit remarkable metabolic diversity, categorized based on how they acquire energy and carbon. These strategies enable survival in various ecological niches and are essential for maintaining energy flow and nutrient cycling within ecosystems.Energy and Carbon SourcesOrganisms are classified as phototrophs or chemotrophs based on energy acquisition. Phototrophs use light as their energy source, while chemotrophs rely on oxidizing chemical compounds. Further differentiation arises...
1.2K
Key Elements for Plant Nutrition
24.1K
Like all living organisms, plants require organic and inorganic nutrients to survive, reproduce, grow and maintain homeostasis. To identify nutrients that are essential for plant functioning, researchers have leveraged a technique called hydroponics. In hydroponic culture systems, plants are grown—without soil—in water-based solutions containing nutrients. At least 17 nutrients have been identified as essential elements required by plants. Plants acquire these elements from the...
24.1K
Clinical Trials
10.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.2K
Clinical Trials: Overview
4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K


